This category feature product approved by FDA and registered with an assigned NDC number, available for private label distribution only. Minimum quantity applies, do not add any with zero $0.00 to your shopping cart.

The hair loss product lines on this collection were born out of several investigational clinical trials by the International Association of Hair Transplant Surgery Organizations and the Board of Hair Restoration Surgery on patients and were found to be effective and 60% equivalent to surgical intervention. The research studies conducted on hair loss patients confirmed not all hair loss is caused by DHT over-production, the board created these products differently from traditional basic minoxidil solutions. The goal is to keep patients healthier and off medication in the shortest possible time, by birthing a pathway of broad-spectrum hair loss treatment that would cover all likely causes of hair loss.

Proof has been established that using Minoxidil alone is not a solution to hair loss, because when discontinued, the hair loss continues. This would mean lifetime dependence on treatment to keep the hair, hence these product formulas were combined with another active ingredient that treats other causes of hair loss present in 70% of women such as-inflammatory scalp and scarring Cicatricial alopecia, follicular degeneration syndrome, and clogged pores.

We register all private label drug products that meet the minimum quantity with FDA as OTC.

For other products approved by FDA specifically for pharmaceutical industry distribution with valid business and professional licenses click here